By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Kite Pharma, Inc. 

2225 Colorado Avenue

Santa Monica  California  90404  U.S.A.
Phone: 301-824-9999 Fax: n/a


Company News
Kite Pharma (KITE) Details KTE-C19 Launch Preparedness And Near-Term, Next Generation CAR/TCR Product Candidates At Investor Day 10/19/2016 8:51:30 AM
How Fast Can Kite Pharma (KITE) File for an Approval of its Lead CAR-T? 10/19/2016 5:37:44 AM
Kite Pharma (KITE) Appoints Chris Nowers As Head Of Europe To Lead Commercial Operations And Advance The Company‚Äôs CAR/TCR Therapy Portfolio In The Region 10/13/2016 11:59:49 AM
Kite Pharma (KITE) To Host Investor Day On October 18, 2016 Spotlighting An Industry-Leading CAR/TCR Pipeline, Next Generation Research And Development, And KTE-C19 Launch Readiness 10/11/2016 11:53:05 AM
Kite Pharma (KITE) Presents 12-Month Follow-Up Data From ZUMA-1 Phase I At The European Society For Medical Oncology (ESMO) Annual Congress 10/7/2016 10:15:42 AM
Kite Pharma (KITE) Initiates Phase Ib/II Combination Study For KTE-C19 And Atezolizumab In Patients With Refractory Diffuse Large B-Cell Lymphoma (DLBCL) 10/6/2016 7:38:47 AM
Kite Pharma (KITE) Names Christine Cassiano As Senior Vice President Of Corporate Communications And Investor Relations 9/30/2016 11:11:47 AM
Kite Pharma (KITE) Claims Success for Phase II CAR-T Study, Stock Soars 9/26/2016 4:30:59 PM
Investors Beware: Thin CAR-T Data Could Make or Break Juno (JUNO) and Kite Pharma (KITE) 9/22/2016 7:05:48 AM
Kite Pharma (KITE) Announces Exclusive License With NIH For Multiple Neoantigen Directed T-Cell Receptor (TCR) Product Candidates To Treat Solid Tumors Expressing Mutated KRAS 9/21/2016 10:08:27 AM